Trademark: 87748391
Status Date
Tuesday, December 7, 2021
Registration Number
6583771
Registration Date
Tuesday, December 7, 2021
Filing Date
Tuesday, January 9, 2018
Published for Opposition
Tuesday, September 4, 2018
9 next-generation sequencing (NGS) data processor; bioinformatics data processor; downloadable computer software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry
5 pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; vaccines; vaccine preparations
42 Providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer; conducting early evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services for others in the field of design, planning, and implementation of clinical trials; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice
The mark consists of 46 line segments radiating out from a natural sun stone shape design.
Color is not claimed as a feature of the mark.
Dec 7, 2021
Registered-Principal Register
Nov 3, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 2, 2021
Allowed Principal Register - Sou Accepted
Oct 28, 2021
Statement Of Use Processing Complete
Oct 26, 2021
Use Amendment Filed
Oct 26, 2021
Teas Statement Of Use Received
Jun 23, 2021
Automatic Update Of Assignment Of Ownership
May 8, 2021
Notice Of Approval Of Extension Request E-Mailed
May 7, 2021
Sou Extension 5 Granted
Apr 29, 2021
Sou Extension 5 Filed
May 7, 2021
Case Assigned To Intent To Use Paralegal
Apr 29, 2021
Teas Extension Received
Oct 16, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 14, 2020
Sou Extension 4 Granted
Oct 14, 2020
Sou Extension 4 Filed
Oct 14, 2020
Teas Extension Received
Aug 5, 2020
Teas Change Of Correspondence Received
Aug 5, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 5, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 12, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 10, 2020
Sou Extension 3 Granted
Mar 10, 2020
Sou Extension 3 Filed
Mar 10, 2020
Teas Extension Received
Oct 4, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 2, 2019
Sou Extension 2 Granted
Oct 2, 2019
Sou Extension 2 Filed
Oct 2, 2019
Teas Extension Received
Mar 27, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 25, 2019
Sou Extension 1 Granted
Mar 25, 2019
Sou Extension 1 Filed
Mar 25, 2019
Teas Extension Received
Oct 30, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 4, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 4, 2018
Published For Opposition
Aug 15, 2018
Notification Of Notice Of Publication E-Mailed
Jul 28, 2018
Approved For Pub - Principal Register
Jul 27, 2018
Teas/Email Correspondence Entered
Jul 26, 2018
Correspondence Received In Law Office
Jul 26, 2018
Teas Response To Office Action Received
Jun 22, 2018
Notification Of Non-Final Action E-Mailed
Jun 22, 2018
Non-Final Action E-Mailed
Jun 22, 2018
Non-Final Action Written
Jun 21, 2018
Teas/Email Correspondence Entered
Jun 20, 2018
Correspondence Received In Law Office
Jun 20, 2018
Teas Response To Office Action Received
Apr 19, 2018
Notification Of Non-Final Action E-Mailed
Apr 19, 2018
Non-Final Action E-Mailed
Apr 19, 2018
Non-Final Action Written
Apr 18, 2018
Assigned To Examiner
Jan 24, 2018
Notice Of Design Search Code E-Mailed
Jan 23, 2018
New Application Office Supplied Data Entered In Tram
Jan 12, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
